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1. INTRODUCTION {#ags312070-sec-0005}
===============

Benchmarking and evaluations of surgical quality have proven beneficial and indispensable for improving surgical quality.[1](#ags312070-bib-0001){ref-type="ref"}, [2](#ags312070-bib-0002){ref-type="ref"} A technique that focuses on the "structure," "process," "results," and "outcomes" of medical care has been proposed as a method for evaluating the quality of medical care, and a variety of other parameters are also being used as indicators in the assessment of surgical quality.[3](#ags312070-bib-0003){ref-type="ref"} For example, number of surgeries has been used as a "structural" indicator, rate of laparoscopic surgeries and length of hospital stay have been used as "process" indicators, and surgery‐related mortality rate, as well as the rate of complications, has been used as "outcome" indicators. In recent years, interest has been increasingly shown in, as well as expectations from, outcome‐oriented evaluations and measurements of medical care quality.

Mortality is an objective indicator, and assessment methods using overall mortality, surgery‐related mortality, in‐hospital mortality, 30‐day mortality, and 90‐day mortality are commonly used. Historically, the 30‐day mortality rate has been used to measure performance across a wide range of surgical disciplines, and the American College of Surgeons National Surgical Quality Improvement Program (ACSNSQIP) database, which is widely considered as the gold standard database for surgical quality improvements and future pay‐for‐performance programs, records 30‐day complication and mortality outcomes after surgery.[4](#ags312070-bib-0004){ref-type="ref"}, [5](#ags312070-bib-0005){ref-type="ref"}, [6](#ags312070-bib-0006){ref-type="ref"} The 30‐day mortality rate, as an objective indicator, may not entirely encompass the overall surgery‐related mortality rate.[7](#ags312070-bib-0007){ref-type="ref"}, [8](#ags312070-bib-0008){ref-type="ref"} As a result of recent progress in medical care, especially advances in anaesthesia[9](#ags312070-bib-0009){ref-type="ref"} and intensive care,[10](#ags312070-bib-0010){ref-type="ref"} early postoperative mortality rates have decreased and survival rates have improved among patients who could have died early after surgery if treated using previous methods. However, this does not necessarily mean that all patients who avoid death during the early postoperative period will continue to survive. Medical circumstances, such as length of hospital stay after surgery, are different in each country, and patients particularly in Europe and the USA are discharged from hospitals during the early postoperative period. As a result, surgery‐related complications that occur after discharge might be impossible to determine on the basis of 30‐day mortality rates or in‐hospital mortality rates. There is an absence of available data pertaining to how much of the surgery‐related mortality rate can be determined based on the 30‐day mortality rate, although this observation varies depending on situations in each country.

Herein, our study examines the significance and validity of the 30‐day mortality rate as a surgery‐related quality indicator (QI).

2. METHODS {#ags312070-sec-0006}
==========

2.1. Data collection {#ags312070-sec-0007}
--------------------

The National Clinical Database (NCD) was established in 2010 as a nationwide database that registers all surgical cases in cooperation with the surgical board certification system. Registrations started in 2011 and, currently, approximately 4300 facilities all over Japan are participating in the registry, and approximately 97% of surgical operations carried out by surgeons have been registered.[11](#ags312070-bib-0011){ref-type="ref"} The NCD, a Web‐based data management system, continuously involves individuals who approve data, those in charge of annual case reports from various departments, and data entry personnel, thereby assuring data traceability. Among gastrointestinal surgeries registered in the NCD, data on items similar to those of the ACSNSQIP have been collected in regard to esophagectomy, total gastrectomy, distal gastrectomy, right hemicolectomy, low anterior resection, hepatectomy, pancreaticoduodenectomy, and acute diffuse peritonitis. Hepatectomy included only extended lobectomy, lobectomy and segmentectomy other than lateral segmentectomy for primary liver cancer or gallbladder cancer.

NCD records between January 1, 2012 and December 31, 2014 were analyzed for this study. The study was conducted on cases of gastrointestinal cancers, which were treated with esophagectomy, total gastrectomy, distal gastrectomy, right hemicolectomy, low anterior resection, hepatectomy, and pancreaticoduodenectomy. To examine the significance and validity of the 30‐day mortality rate as a surgical QI, the study was carried out without including acute diffuse peritonitis, in which the patient\'s condition before surgery may have a great influence on the mortality rate. In addition, cases of non‐curative resection were excluded to exclude cancer‐related deaths. In order to increase the quality of the endpoints, a longer duration was given to the postoperative observation period, and data on surgical cases operated between January and June, which allowed for acquisition of follow‐up data from 30 days to 180 days after surgery, were analyzed. Records from patients who refused use of their data were excluded from this analysis. Records with missing data for age, gender, or status at postoperative day 30 were also excluded. Because non‐curative resection cases had been excluded, postoperative mortality was equivalent to surgery‐related mortality and, therefore, was considered as an endpoint.

2.2. Mortality curve for each operative procedure {#ags312070-sec-0008}
-------------------------------------------------

Mortality curves were drawn using death within 30 days or postoperative death as events to visualize when mortality events occurred in the postoperative course.

2.3. Sensitivity of surgery‐related mortality (capture ratio) {#ags312070-sec-0009}
-------------------------------------------------------------

In order to assess the mortality at various time points, ranging from 30 days to 180 days, which covers the surgery‐related mortality rate, we calculated the sensitivity of mortality at each point (capture ratio) on the basis of the 210‐day mortality, and we also calculated respective 95% confidence intervals.

2.4. Association between mortality within 30 days, mortality after 31 days, and preoperative, perioperative, and postoperative factors {#ags312070-sec-0010}
--------------------------------------------------------------------------------------------------------------------------------------

Preoperative, perioperative, and postoperative factors, extracted during the creation of surgery‐related mortality models, were used for examining association of mortality within 30 days and after 31 days. We investigated the distribution of patients who died within 30 days as well as that of patients who died after the 31st day, and the difference between the two was tested using Fisher\'s exact test. In both categories, a two‐sided *P*‐value of \<.05 was considered statistically significant. Statistical analyses were carried out using STATA14 (Stata Corp., College Station, TX, USA).

The present study followed the ethical guidelines of human subjects based on the Helsinki Declaration. Review and approval by the ethics committee was not carried out because existing unlinkable, anonymized data were used in the present study.

3. RESULTS {#ags312070-sec-0011}
==========

3.1. Subjects {#ags312070-sec-0012}
-------------

Our study included 7448 cases of esophagectomy, 22 453 cases of total gastrectomy, 48 774 cases of distal gastrectomy, 24 260 cases of right hemicolectomy, 27 046 cases of low anterior resection, 7486 cases of hepatectomy, and 10 550 cases of pancreaticoduodenectomy. Among patients with esophagectomies, 39.5% presented a history of smoking tobacco within 1 year before surgery, and 62.0% had an alcohol‐consumption habit before surgery. Among patients with hepatectomies and those with pancreaticoduodenectomies, patients who were diagnosed with diabetes mellitus before surgery accounted for 28.1% and 30.2%, respectively, and these rates were higher than those found in patients undergoing other surgical procedures. Patients with intraoperative blood loss of 1000 mL or more accounted for 37.9% of those treated for hepatectomies, and 34.2% of those treated for pancreaticoduodenectomies, and patients with postoperative complications of Clavien‐Dindo classification grade III or greater accounted for 16.9% of those treated for esophagectomies and 16.0% of those treated for pancreaticoduodenectomies. Patients with postoperative anastomotic leakage accounted for 11.6% of those treated for esophagectomies, 8.5% of those treated for low anterior resections, and 10.6% of those treated for pancreaticoduodenectomies. Finally, 20.7% of patients treated for pancreaticoduodenectomies developed pancreatic fistulas (any grade), 2.3% developed grade C pancreatic fistulas, and bile leakage was present in 6.7% of patients treated for hepatectomies (Table [1](#ags312070-tbl-0001){ref-type="table-wrap"}).

###### 

Characteristics of analyzed subjects

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                  Esophagectomy (n = 7448)   Total gastrectomy (n = 22 453)   Distal gastrectomy (n = 48 774)   Right hemicolectomy (n = 24 260)   Low anterior resection (n = 27 046)   Hepatectomy (n = 7486)   Pancreaticoduodenectomy (n = 10 550)   Total (n = 148 017)                                                                        
  ----------------------------------------------- -------------------------- -------------------------------- --------------------------------- ---------------------------------- ------------------------------------- ------------------------ -------------------------------------- --------------------- -------- -------- ------- ------ ------ -------- --------- --------- -------
  Age (y)                                         ‐59                        1387                             18.6                              3340                               14.9                                  7953                     16.3                                   2569                  10.6     6085     22.5    989    13.2   1372     13.0      23 695    16.0

  60‐64                                           1477                       19.8                             3148                              14.0                               7005                                  14.4                     2377                                   9.8                   4587     17.0     1056    14.1   1474   14.0     21 124    14.3      

  65‐69                                           1671                       22.4                             3652                              16.3                               7675                                  15.7                     3247                                   13.4                  4806     17.8     1305    17.4   1983   18.8     24 339    16.4      

  70‐74                                           1586                       21.3                             4553                              20.3                               8877                                  18.2                     4464                                   18.4                  4698     17.4     1618    21.6   2361   22.4     28 157    19.0      

  75‐79                                           947                        12.7                             4207                              18.7                               8339                                  17.1                     4732                                   19.5                  3607     13.3     1659    22.2   2122   20.1     25 613    17.3      

  80‐                                             380                        5.1                              3553                              15.8                               8925                                  18.3                     6871                                   28.3                  3263     12.1     859     11.5   1238   11.7     25 089    17.0      

  Gender                                          Female                     1223                             16.4                              5701                               25.4                                  16 204                   33.2                                   12 450                51.3     9442     34.9    2042   27.3   4164     39.5      51 226    34.6

  Male                                            6225                       83.6                             16 752                            74.6                               32 570                                66.8                     11 810                                 48.7                  17 604   65.1     5444    72.7   6386   60.5     96 791    65.4      

  Smoking habits                                  (‐)                        4509                             60.5                              17 534                             78.1                                  38 700                   79.3                                   21 378                88.1     21 410   79.2    6077   81.2   8657     82.1      118 265   79.9

  (+)                                             2939                       39.5                             4919                              21.9                               10 074                                20.7                     2882                                   11.9                  5636     20.8     1409    18.8   1893   17.9     29 752    20.1      

  Drinking habits                                 (‐)                        2830                             38.0                              16 000                             71.3                                  35 455                   72.7                                   20 008                82.5     19 739   73.0    5477   73.2   7950     75.4      107 459   72.6

  (+)                                             4618                       62.0                             6453                              28.7                               13 319                                27.3                     4252                                   17.5                  7307     27.0     2009    26.8   2600   24.6     40 558    27.4      

  Hypertension                                    (‐)                        5033                             67.6                              14 128                             62.9                                  30 376                   62.3                                   14 715                60.7     17 790   65.8    4407   58.9   6595     62.5      93 044    62.9

  (+)                                             2415                       32.4                             8325                              37.1                               18 398                                37.7                     9545                                   39.3                  9256     34.2     3079    41.1   3955   37.5     54 973    37.1      

  Diabetes                                        (‐)                        6507                             87.4                              18 488                             82.3                                  40 319                   82.7                                   19 876                81.9     22 305   82.5    5385   71.9   7369     69.8      120 249   81.2

  (+)                                             941                        12.6                             3965                              17.7                               8455                                  17.3                     4384                                   18.1                  4741     17.5     2101    28.1   3181   30.2     27 768    18.8      

  Chronic obstructive pulmonary disease           (‐)                        6945                             93.2                              21 405                             95.3                                  46 734                   95.8                                   23 568                97.1     26 221   96.9    7219   96.4   10 253   97.2      142 345   96.2

  (+)                                             503                        6.8                              1048                              4.7                                2040                                  4.2                      692                                    2.9                   825      3.1      267     3.6    297    2.8      5672      3.8       

  Brain disorder                                  (‐)                        7273                             97.7                              21 610                             96.2                                  46 946                   96.3                                   23 295                96.0     26 181   96.8    7273   97.2   10 214   96.8      142 792   96.5

  (+)                                             175                        2.3                              843                               3.8                                1828                                  3.7                      965                                    4.0                   865      3.2      213     2.8    336    3.2      5225      3.5       

  ≥ASA2                                           (‐)                        2418                             32.5                              6986                               31.1                                  16 262                   33.3                                   6649                  27.4     9829     36.3    1732   23.1   2678     25.4      46 554    31.5

  (+)                                             5030                       67.5                             15 467                            68.9                               32 512                                66.7                     17 611                                 72.6                  17 217   63.7     5754    76.9   7872   74.6     101 463   68.5      

  Intraoperative cardiac complications            (‐)                        7438                             99.9                              22 443                             100.0                                 48 755                   100.0                                  24 251                100.0    27 037   100.0   7481   99.9   10 547   100.0     14 7952   100.0

  (+)                                             10                         0.1                              10                                0.0                                19                                    0.0                      9                                      0.0                   9        0.0      5       0.1    3      0.0      65        0.0       

  Intraoperative blood loss ≥1000 mL              (‐)                        6709                             90.1                              20 261                             90.2                                  47 436                   97.3                                   23 718                97.8     25 721   95.1    4649   62.1   6938     65.8      135 432   91.5

  (+)                                             739                        9.9                              2192                              9.8                                1338                                  2.7                      542                                    2.2                   1325     4.9      2837    37.9   3612   34.2     12 585    8.5       

  Postoperative complications\                    (‐)                        6188                             83.1                              20 642                             91.9                                  46 507                   95.4                                   23 195                95.6     24 612   91.0    6595   88.1   8867     84.0      136 606   92.3
  Clavien‐Dindo classification ≥grade III                                                                                                                                                                                                                                                                                                                                           

  (+)                                             1260                       16.9                             1811                              8.1                                2267                                  4.6                      1065                                   4.4                   2434     9.0      891     11.9   1683   16.0     11 411    7.7       

  Postoperative complications\                    (‐)                        7199                             96.7                              22 118                             98.5                                  48 322                   99.1                                   24 044                99.1     26 782   99.0    7268   97.1   10 251   97.2      145 984   98.6
  Clavien‐Dindo classification ≥grade IV                                                                                                                                                                                                                                                                                                                                            

  (+)                                             249                        3.3                              335                               1.5                                452                                   0.9                      216                                    0.9                   264      1.0      218     2.9    299    2.8      2033      1.4       

  Reoperation within 30 days after operation      (‐)                        6768                             90.9                              21 332                             95.0                                  47 301                   97.0                                   23 414                96.5     24 654   91.2    7218   96.4   9882     93.7      140 569   95.0

  (+)                                             680                        9.1                              1121                              5.0                                1473                                  3.0                      846                                    3.5                   2392     8.8      268     3.6    668    6.3      7448      5.0       

  Surgical site infection\                        (‐)                        6828                             91.7                              21 304                             94.9                                  47 406                   97.2                                   23 016                94.9     25 835   95.5    7042   94.1   9458     89.6      140 889   95.2
  other than anastomotic leakage                                                                                                                                                                                                                                                                                                                                                    

  (+)                                             620                        8.3                              1149                              5.1                                1368                                  2.8                      1244                                   5.1                   1211     4.5      444     5.9    1092   10.4     7128      4.8       

  Anastomotic leakage                             (‐)                        6584                             88.4                              21 524                             95.9                                  47 749                   97.9                                   23 929                98.6     24 741   91.5    7373   98.5   9432     89.4      141 332   95.5

  (+)                                             864                        11.6                             929                               4.1                                1025                                  2.1                      331                                    1.4                   2305     8.5      113     1.5    1118   10.6     6685      4.5       

  Transfusion ≥5 U                                (‐)                        7279                             97.7                              22 234                             99.0                                  48 502                   99.4                                   24 144                99.5     26 914   99.5    7224   96.5   10 220   96.9      146 517   99.0

  (+)                                             169                        2.3                              219                               1.0                                272                                   0.6                      116                                    0.5                   132      0.5      262     3.5    330    3.1      1500      1.0       

  Postoperative unexpected intubation             (‐)                        7012                             94.1                              22 165                             98.7                                  48 414                   99.3                                   24 150                99.5     26 909   99.5    7353   98.2   10 334   98.0      146 337   98.9

  (+)                                             436                        5.9                              288                               1.3                                360                                   0.7                      110                                    0.5                   137      0.5      133     1.8    216    2.0      1680      1.1       

  Postoperative mechanical ventilation ≥48 h      (‐)                        6881                             92.4                              22 157                             98.7                                  48 418                   99.3                                   24 099                99.3     26 878   99.4    7332   97.9   10 313   97.8      146 078   98.7

  (+)                                             567                        7.6                              296                               1.3                                356                                   0.7                      161                                    0.7                   168      0.6      154     2.1    237    2.2      1939      1.3       

  Postoperative renal dysfunction                 (‐)                        7318                             98.3                              22 264                             99.2                                  48 493                   99.4                                   24 121                99.4     26 852   99.3    7331   97.9   10 378   98.4      146 757   99.1

  (+)                                             130                        1.7                              189                               0.8                                281                                   0.6                      139                                    0.6                   194      0.7      155     2.1    172    1.6      1260      0.9       

  Postoperative central nervous system disorder   (‐)                        7430                             99.8                              22 400                             99.8                                  48 689                   99.8                                   24 215                99.8     26 998   99.8    7476   99.9   10 528   99.8      147 736   99.8

  (+)                                             18                         0.2                              53                                0.2                                85                                    0.2                      45                                     0.2                   48       0.2      10      0.1    22     0.2      281       0.2       

  Postoperative cardiac complications             (‐)                        7389                             99.2                              22 360                             99.6                                  48 653                   99.8                                   24 203                99.8     26 981   99.8    7445   99.5   10 478   99.3      147 509   99.7

  (+)                                             59                         0.8                              93                                0.4                                121                                   0.2                      57                                     0.2                   65       0.2      41      0.5    72     0.7      508       0.3       

  Postoperative sepsis                            (‐)                        7066                             94.9                              21 954                             97.8                                  48 198                   98.8                                   23 978                98.8     26 509   98.0    7299   97.5   10 096   95.7      145 100   98.0

  (+)                                             382                        5.1                              499                               2.2                                576                                   1.2                      282                                    1.2                   537      2.0      187     2.5    454    4.3      2917      2.0       

  Postoperative septic shock                      (‐)                        7364                             98.9                              22 324                             99.4                                  48 618                   99.7                                   24 156                99.6     26 921   99.5    7438   99.4   10 447   99.0      147 268   99.5

  (+)                                             84                         1.1                              129                               0.6                                156                                   0.3                      104                                    0.4                   125      0.5      48      0.6    103    1.0      749       0.5       

  Postoperative pneumonia                         (‐)                        6543                             87.8                              21 783                             97.0                                  47 884                   98.2                                   23 991                98.9     26 844   99.3    7364   98.4   10 316   97.8      144 725   97.8

  (+)                                             905                        12.2                             670                               3.0                                890                                   1.8                      269                                    1.1                   202      0.7      122     1.6    234    2.2      3292      2.2       

  Postoperative deep vein thrombosis              (‐)                        7413                             99.5                              22 415                             99.8                                  48 714                   99.9                                   24 212                99.8     26 983   99.8    7460   99.7   10 511   99.6      147 708   99.8

  (+)                                             35                         0.5                              38                                0.2                                60                                    0.1                      48                                     0.2                   63       0.2      26      0.3    39     0.4      309       0.2       

  Postoperative pulmonary embolism                (‐)                        7428                             99.7                              22 429                             99.9                                  48 727                   99.9                                   24 244                99.9     27 011   99.9    7465   99.7   10 521   99.7      147 825   99.9

  (+)                                             20                         0.3                              24                                0.1                                47                                    0.1                      16                                     0.1                   35       0.1      21      0.3    29     0.3      192       0.1       

  Postoperative urinary tract infection           (‐)                        7406                             99.4                              22 353                             99.6                                  48 589                   99.6                                   24 134                99.5     26 783   99.0    7440   99.4   10 471   99.3      147 176   99.4

  (+)                                             42                         0.6                              100                               0.4                                185                                   0.4                      126                                    0.5                   263      1.0      46      0.6    79     0.7      841       0.6       

  Postoperative pancreatic fistula                (‐)                                                                                           21 394                             95.3                                  47 929                   98.3                                                                                                 8363     79.3      77 686    95.0

  (+)                                                                                                         1059                              4.7                                845                                   1.7                                                                                                                    2187   20.7     4091      5.0       

  Postoperative pancreatic fistula\               (‐)                                                                                           22 382                             99.7                                  48 706                   99.9                                                                                                 10 304   97.7      81 392    99.5
  ≥grade C                                                                                                                                                                                                                                                                                                                                                                          

  (+)                                                                                                         71                                0.3                                68                                    0.1                                                                                                                    246    2.3      385       0.5       

  Postoperative biliary fistula                   (‐)                                                                                                                                                                                                                                                                                    6981   93.3                      6981      93.3

  (+)                                                                                                                                                                                                                                                                                                                            505     6.7                    505       6.7       
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ASA2, American Society of Anesthesiologists Classification 2.

John Wiley & Sons, Ltd

3.2. Mortality curves for each surgical procedure {#ags312070-sec-0013}
-------------------------------------------------

When survival or death at day 210 was used as an endpoint, the surgery‐related mortality rate was 3.0% for patients with hepatectomies, 2.5% for patients with pancreaticoduodenectomies, 2.3% for patients with esophagectomies, 1.4% for patients with total gastrectomies, 1.1% for patients with right hemicolectomies, 0.8% for patients with distal gastrectomies, and 0.6% for patients with low anterior resections, respectively, in descending order. All types of surgical procedures showed mortality rates that increased over time.

For right hemicolectomies, low anterior resections, and hepatectomies, the mortality rate nearly reached a plateau between days 90 and 150. For esophagectomies, total gastrectomies, gastrectomies, and pancreaticoduodenectomies, the mortality rate continuously increased until day 210 (Figure [1](#ags312070-fig-0001){ref-type="fig"}).

![Mortality curve for each type of surgical procedure. A, Esophagectomy; B, Total gastrectomy; C, Distal gastrectomy; D, Right hemicolectomy; E, Low anterior resection; F, Hepatectomy; G, Pancreaticoduodenectomy](AGS3-2-231-g001){#ags312070-fig-0001}

3.3. Sensitivity of the 30‐to‐180‐day mortality rate (capture ratio for surgery‐related mortalities) in comparison with the 210‐day mortality rate (surgery‐related mortalities) {#ags312070-sec-0014}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The 30‐day mortality rate captured only 38.7% (esophagectomies) to 53.3% (right hemicolectomies) of surgery‐related mortalities. The capture ratio for surgery‐related mortalities reached 90% or greater when the 120‐day mortality rate was taken into consideration for right hemicolectomy, low anterior resection, hepatectomy, and pancreaticoduodenectomy, as well as when the 150‐day mortality rate was taken into account for esophagectomy, total gastrectomy, and distal gastrectomy. The capture ratio for surgery‐related mortalities reached 90% or greater when the 120‐day mortality rate was taken into consideration for right hemicolectomy, low anterior resection, hepatectomy, and pancreaticoduodenectomy, and when the 150‐day mortality rate was taken into consideration for esophagectomy, total gastrectomy and distal gastrectomy. The capture ratio of 90‐day mortality rate was 80.3% in esophagectomies, 80.3% in total gastrectomies, 81.6% in distal gastrectomies, 89.0% in right hemicolectomies, 88.5% in low anterior resections, 85.2% in hepatectomies and 81.2% in pancreaticoduodenectomies (Table [2](#ags312070-tbl-0002){ref-type="table-wrap"}).

###### 

Sensitivity of the 30‐to‐180‐day mortality rate (capture ratio for surgery‐related mortalities)

                            30 d               60 d               90 d               120 d              150 d              180 d
  ------------------------- ------------------ ------------------ ------------------ ------------------ ------------------ --------------------
  Esophagectomy             38.7 (31.4‐46.4)   64.7 (57.1‐71.8)   80.3 (73.6‐85.9)   87.2 (81.3‐91.8)   93.0 (88.1‐96.3)   96.5 (92.6‐98.7)
  Total gastrectomy         47.3 (41.7‐52.9)   66.3 (60.8‐71.5)   80.3 (75.6‐84.5)   88.7 (84.8‐92.0)   93.4 (90.1‐95.9)   97.8 (95.6‐99.1)
  Distal gastrectomy        48.3 (43.4‐53.2)   68.1 (63.3‐72.5)   81.6 (77.5‐85.2)   89.3 (85.9‐92.1)   95.1 (92.6‐97.0)   97.6 (95.6‐98.8)
  Right hemicolectomy       53.3 (47.1‐59.4)   74.4 (68.7‐79.5)   89.0 (84.7‐92.5)   95.4 (92.2‐97.6)   98.4 (96.1‐99.5)   100.0 (98.6‐100.0)
  Low anterior resection    50.9 (42.8‐59.0)   76.4 (69.0‐82.8)   88.5 (82.4‐93.0)   94.2 (89.3‐97.3)   97.4 (93.6‐99.3)   98.7 (95.5‐99.8)
  Hepatectomy               42.6 (36.0‐49.3)   69.9 (63.4‐75.8)   85.2 (79.8‐89.5)   94.6 (90.7‐97.1)   97.7 (94.8‐99.2)   99.6 (97.5‐100.0)
  Pancreaticoduodenectomy   42.9 (36.9‐49.0)   68.2 (62.3‐73.8)   81.3 (76.1‐85.8)   91.0 (86.9‐94.1)   95.1 (91.8‐97.3)   98.5 (96.2‐99.6)
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3.4. Association between mortality within 30 days, mortality after 31 days, and preoperative, perioperative and postoperative factors {#ags312070-sec-0015}
-------------------------------------------------------------------------------------------------------------------------------------

Among factors that likely affect surgery‐related mortality rates, the following showed a significantly higher percentage of deaths within 30 days, irrespective of the type of surgical procedure: postoperative complications of Clavien‐Dindo classification grade III or higher (except esophagectomy), postoperative complications of Clavien‐Dindo classification grade IV or higher (all surgical procedures), unplanned postoperative intubation (except esophagectomy and hepatectomy), and cardiac complications (all surgical procedures). In addition, the following factors were associated with individual surgical procedures: renal dysfunction (distal gastrectomy, right hemicolectomy), central nervous system disorder (right hemicolectomy), sepsis (right hemicolectomy), and septic shock (total gastrectomy, low anterior resection). Conversely, the following factors displayed significantly lower percentages in terms of mortality within 30 days: reoperation within 30 days (esophagectomy, total gastrectomy, right hemicolectomy, pancreaticoduodenectomy), anastomotic leakage (total gastrectomy, distal gastrectomy), pulmonary embolism (low anterior resection), pneumonia (hepatectomy), and urinary tract infection (total gastrectomy, right hemicolectomy) (Table [3](#ags312070-tbl-0003){ref-type="table-wrap"}).

###### 

Association between mortality within 30 d, mortality after 31 d, and preoperative, perioperative and postoperative factors

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                               Esophagectomy    Total gastrectomy   Distal gastrectomy   Right colectomy    Low anterior resection   Hepatectomy   Pancreaticoduodenectomy                                                                                                                                                                                                                            
  ------------------------------------------------------------ ---------------- ------------------- -------------------- ------------------ ------------------------ ------------- ------------------------- ------------------ ------------ ----------------- ---------------- ------------ ----------------- ---------------- ------------ ------------------ ------------------ ------------ ------------------ ------------------ ------------
  Age (‐59/60‐64/65‐69/70‐74/75‐79/80‐)                        4/14/8/17/18/6   8/17/21/25/24/11    .763                 4/11/13/21/48/55   6/10/21/20/47/65         .811          11/10/18/88/38/90         5/6/15/30/52/106   .251         7/6/10/16/25/78   2/3/5/9/19/86    .203         7/9/11/13/12/28   1/9/7/7/16/37    .113         3/14/14/29/24/11   8/21/19/24/36/20   .419         6/13/22/25/23/26   8/10/23/37/39/36   .635

  Gender (F/M)                                                 6/61             7/99                .568                 26/126             31/138                   .884          52/148                    56/158             1.000        63/79             60/64            .539         17/63             15/62            .844         21/74              30/98              .873         27/88              36/117             1.000

  Smoking habits (+)                                           36 (53.7%)       48 (45.3%)          .349                 **19 (12.5%)**     **36 (21.3%)**           **.039**      31 (15.5%)                29 (13.6%)         .580         9 (6.3%)          14 (11.3%)       .190         19 (23.8%)        13 (16.9%)       .325         20 (21.1%)         32 (25.0%)         .525         25 (21.7%)         22 (14.4%)         .144

  Drinking habits (+)                                          39 (58.2%)       67 (63.2%)          .526                 30 (19.7%)         42 (24.9%)               .287          31 (15.5%)                47 (22.0%)         .103         17 (12.0%)        16 (12.9%)       .854         17 (21.3%)        14 (18.2%)       .691         22 (23.2%)         39 (30.5%)         .288         27 (23.5%)         36 (23.5%)         1.000

  Hypertension (+)                                             32 (47.8%)       41 (38.7%)          .270                 63 (41.4%)         73 (43.2%)               .821          97 (48.5%)                88 (41.1%)         .139         60 (42.3%)        61 (49.2%)       .269         31 (38.8%)        30 (39.0%)       1.000        42 (44.2%)         61 (47.7%)         .684         63 (54.8%)         80 (52.3%)         .712

  Diabetes (+)                                                 16 (23.9%)       20 (18.9%)          .447                 24 (15.8%)         14 (8.3%)                .053          49 (24.5%)                52 (24.3%)         1.000        26 (18.3%)        28 (22.6%)       .446         20 (25.0%)        21.0 (27.3%)     .856         26 (27.4%)         43 (33.6%)         .380         43 (37.4%)         60 (39.2%)         .800

  Chronic obstructive pulmonary disease (+)                    8 (11.9%)        13 (12.3%)          1.000                15 (9.9%)          14 (8.3 %)               .698          21 (10.5%)                21 (9.8%)          .871         9 (6.3%)          10 (8.1%)        .638         5 (6.3%)          3 (3.9%)         .720         4 (4.2%)           7 (5.5%)           .762         10 (8.7%)          8 (5.2%)           .326

  Brain disorder (+)                                           3 (4.5%)         4 (3.8%)            1.000                24 (15.8%)         16 (9.5%)                .093          21 (10.5%)                19 (8.9%)          .620         14 (9.9%)         9 (7.3%)         .516         12 (15.0%)        9 (11.7%)        .641         5 (5.3%)           7 (5.5%)           1.000        8 (7.0%)           14 (9.2%)          .654

  ≥ASA2                                                        57 (85.1%)       89 (84.0%)          1.000                130 (85.5%)        138 (81.7%)              .370          184 (92.0%)               194 (90.7%)        .728         131 (92.3%)       119 (96.0%)      .301         68 (85.0%)        65 (84.4%)       1.000        84 (88.4%)         109 (85.2%)        .554         102 (88.7%)        134 (87.6%)        .850

  Intraoperative cardiac complications (+)                     2 (3.0%)         0 (0.0%)            .149                 2 (1.3%)           0 (0.0 %)                .223          2 (1.0%)                  0 (0.0%)           .233         3 (2.1%)          0 (0.0%)         .251         1 (1.3%)          0 (0.0%)         1.000        1 (1.1%)           0 (0.0%)           .426         0 (0.0%)           0 (0.0%)            

  Intraoperative blood loss ≥1000 mL                           18 (26.9%)       27 (25.5%)          .860                 32 (21.1%)         46 (27.2%)               .241          18 (9.0%)                 32 (15.0%)         .071         11 (7.7%)         17 (13.7%)       .160         12 (15.0%)        12 (15.6%)       1.000        65 (68.4%)         88 (68.8%)         1.000        70 (60.9%)         81 (52.9%)         .215

  Postoperative complications\                                 55 (82.1%)       79 (74.5%)          .268                 **131 (86.2%)**    **103 (60.9%)**          **\<.001**    **159 (79.5%)**           **118 (55.1%)**    **\<.001**   **113 (79.6%)**   **57 (46.0%)**   **\<.001**   **66 (82.5%)**    **44 (57.1%)**   **\<.001**   **88 (92.6%)**     **90 (70.3%)**     **\<.001**   **104 (90.4%)**    **107 (69.9%)**    **\<.001**
  Clavien‐Dindo classification ≥grade III (+)                                                                                                                                                                                                                                                                                                                                                                                         

  Postoperative complications\                                 **55 (82.1%)**   **51 (48.1%)**      **\<.001**           **127 (83.6%)**    **64 (37.9%)**           **\<.001**    **148 (74.0%)**           **78 (36.4%)**     **\<.001**   **108 (76.1%)**   **29 (23.4%)**   **\<.001**   **63 (78.8%)**    **26 (33.8%)**   **\<.001**   **87 (91.6%)**     **63 (49.2%)**     **\<.001**   **100 (87.0%)**    **67 (43.8%)**     **\<.001**
  Clavien‐Dindo classification ≥grade IV (+)                                                                                                                                                                                                                                                                                                                                                                                          

  Reoperation within 30 days after operation (+)               **19 (28.4%)**   **48 (45.3%)**      **.037**             **46 (30.3%)**     **74 (43.8%)**           **.015**      54 (27.0%)                70 (32.7%)         .238         **20 (14.1%)**    **35 (28.2%)**   **.006**     34 (42.5%)        32 (41.6%)       1.000        21 (22.1%)         32 (25.0%)         .637         **40 (34.8%)**     **72 (47.1%)**     **.046**

  Surgical site infection other than anastomotic leakage (+)   **6 (9.0 %)**    **31 (29.2%)**      **.001**             **12 (7.9%)**      **30 (17.8%)**           **.012**      **15 (7.5%)**             **44 (20.6%)**     **\<.001**   **19 (13.4%)**    **31 (25.0%)**   **.018**     14 (17.5%)        18 (23.4%)       .430         **4 (4.2%)**       **34 (26.6%)**     **\<.001**   **19 (16.5%)**     **52 (34.0%)**     **.001**

  Anastomotic leakage (+)                                      15 (22.4%)       38 (35.8%)          .065                 **22 (14.5%)**     **53 (31.4%)**           **\<.001**    **28 (14.0%)**            **49 (22.9%)**     **.023**     19 (13.4%)        20 (16.1%)       .603         30 (37.5%)        27 (35.1%)       .868         4 (4.2%)           15 (11.7%)         .054         40 (34.8%)         67 (43.8%)         .166

  Transfusion ≥5 U (+)                                         17 (25.4%)       29 (27.4%)          .860                 36 (23.7%)         30 (17.8%)               .214          37 (18.5%)                44 (20.6%)         .622         18 (12.7%)        13 (10.5%)       .702         15 (18.8%)        16 (20.8%)       .842         47 (49.5%)         55 (43.0%)         .345         53 (46.1%)         61 (39.9%)         .321

  Postoperative unexpected intubation (+)                      33 (49.3%)       52 (49.1%)          1.000                **77 (50.7%)**     **52 (30.8%)**           **\<.001**    **98 (49.0%)**            **58 (27.1%)**     **\<.001**   **32 (22.5%)**    **14 (11.3%)**   **.022**     **34 (42.5%)**    **20 (26.0%)**   **.043**     42 (44.2%)         41 (32.0%)         .070         **56 (48.7%)**     **54 (35.3%)**     **.033**

  Postoperative mechanical ventilation ≥48 h (+)               35 (52.2%)       62 (58.5%)          .436                 59 (38.8%)         55 (32.5%)               .246          75 (37.5%)                68 (31.8%)         .255         39 (27.5%)        28 (22.6%)       .397         29 (36.3%)        21 (27.3%)       .237         41 (43.2%)         47 (36.7%)         .336         48 41.7%)          61 (39.9%)         .802

  Postoperative renal dysfunction (+)                          22 (32.8%)       28 (26.4%)          .392                 44 (28.9%)         38 (22.5%)               .201          **61 (30.5%)**            **44 (20.6%)**     **.024**     **35 (24.6%)**    **17 (13.7%)**   **.030**     27 (33.8%)        16 (20.8%)       .076         41 (43.2%)         42 (32.8%)         .125         38 (33.0%)         43 (28.1%)         .421

  Postoperative central nervous system disorder (+)            0 (0.0%)         1 (0.9%)            1.000                10 (6.6%)          7 ( 4.1%)                .455          8 (4.0%)                  3 (1.4%)           .130         **9 (6.3%)**      **1 (0.8%)**     **.022**     7 (8.8%)          2 (2.6%)         .168         1 (1.1%)           0 (0.0%)           .426         3 (2.6%)           5 (3.3%)           1.000

  Postoperative cardiac complications (+)                      **33 (49.3%)**   **11 (10.4%)**      **\<.001**           **63 (41.4%)**     **12 (7.1%)**            **\<.001**    **76 (38.0%)**            **12 (5.6%)**      **\<.001**   **41 (28.9%)**    **2 (1.6%)**     **\<.001**   **38 (47.5%)**    **11 (14.3%)**   **\<.001**   **29 (30.5%)**     **7 (5.5%)**       **\<.001**   **46 (40.0%)**     **9 (5.9%)**       **\<.001**

  Postoperative sepsis (+)                                     34 (50.7%)       47 (44.3%)          .437                 55 (36.2%)         50 (29.6%)               .234          62 (31.0%)                70 (32.7%)         .752         **46 (32.4%)**    **26 (21.0%)**   **.039**     33 (41.3%)        22 (28.6%)       .132         25 (26.3%)         45 (35.2%)         .190         40 (34.8%)         66 (43.1%)         .207

  Postoperative septic shock (+)                               24 (35.8%)       26 (24.5%)          .124                 **36 (23.7%)**     **24 (14.2%)**           **.032**      39 (19.5%)                39 (18.2%)         .802         34 (23.9%)        19 (15.3%)       .091         **29 (36.3%)**    **9 (11.7%)**    **\<.001**   11 (11.6%)         24 (18.8%)         .192         27 (23.5%)         34 (22.2%)         .883

  Postoperative pneumonia (+)                                  34 (50.7%)       55 (51.9%)          1.000                46 (30.3%)         67 (39.6%)               .081          63 (31.5%)                70 (32.7%)         .833         25 (17.6%)        32 (25.8%)       .134         16 (20.0%)        22 (28.6%)       .264         **9 (9.5%)**       **37 (28.9%)**     **\<.001**   27 (23.5%)         42 (27.5%)         .484

  Postoperative deep vein thrombosis (+)                       0 (0.0%)         0 (0.0%)                                 3 (2.0%)           5 (3.0%)                 .726          3 (1.5%)                  2 (0.9%)           .676         5 (3.5%)          0 (0.0%)         .063         4 (5.0%)          1 (1.3%)         .367         3 (3.2%)           1 (0.8%)           .315         2 (1.7%)           2 (1.3%)           1.000

  Postoperative pulmonary embolism (+)                         0 (0.0%)         0 (0.0%)                                 2 (1.3%)           3 (1.8%)                 1.000         4 (2.0%)                  2 (0.9%)           .163         2 (1.4%)          0 (0.0%)         .500         **6 (7.5%)**      **0 (0.0%)**     **.028**     0 (0.0%)           1 (0.8%)           1.000        5 (4.3%)           1 (0.7%)           .087

  Postoperative urinary tract infection (+)                    1 (1.5%)         8 (7.5%)            .156                 **0 (0.0%)**       **8 (4.7%)**             **.008**      4 (2.0%)                  9 (4.2%)           .263         **4 (2.8%)**      **12 (9.7%)**    **.021**     2 (2.5%)          8 (10.4%)        .053         5 (5.3%)           6 (4.7%)           1.000        3 (2.6%)           10 (6.5%)          .162

  Postoperative pancreatic fistula (+)                                                                                   11 (7.2%)          21 (12.4%)               .138          10 (5.0%)                 13 (6.1%)          .673                                                                                                                                                            48 (41.7%)         72 (47.1%)         .457

  Postoperative pancreatic fistula\                                                                                      4 (2.6%)           10 (5.9%)                .179          6 (3.0%)                  8 (3.7%)           .789                                                                                                                                                            29 (25.2%)         39 (25.5%)         1.000
  ≥grade C (+)                                                                                                                                                                                                                                                                                                                                                                                                                        

  Postoperative biliary fistula (+)                                                                                                                                                                                                                                                                                                          8 (8.4%)           34 (26.6%)         .001                                                
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ASA2, American Society of Anesthesiologists Classification 2.

The significance of bolded terms was "*P* \< 0.05".
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4. DISCUSSION {#ags312070-sec-0016}
=============

We found that the 30‐day mortality, which was a standard QI for international comparisons, was not sufficient as a QI for all gastrointestinal cancer surgeries. Surgical stress, risk of complications, surgery‐related mortality rate, and the 30‐day mortality differ depending on the type of surgical procedure. Even when the type of surgical procedure was identical, the risk of surgery‐related deaths and complications varied depending on patient‐related risks, such as age and comorbidities.[12](#ags312070-bib-0012){ref-type="ref"}, [13](#ags312070-bib-0013){ref-type="ref"}, [14](#ags312070-bib-0014){ref-type="ref"} However, from an overall perspective, the risk roughly reflects the difference associated with the type of surgical procedure. Also, in our data, surgery‐related mortality rates varied depending on the type of surgical procedure, where highest values were found in hepatectomies and lowest in low anterior resections. Previous reports, based on a comparison of 30‐day mortality rates, have shown that surgical outcomes were more favorable in Japan than in Europe and the USA.[15](#ags312070-bib-0015){ref-type="ref"}

The number of surgeries carried out, rate of laparoscopic surgeries, length of hospital stay, surgery‐related mortality rates, and rate of complications have been used as indicators for the evaluation of surgical outcomes, or qualities, in individual facilities, and have been used for comparisons between facilities in terms of outcomes (qualities). However, the number of surgeries carried out by each facility, as well as the length of hospital stay, varies depending on each country\'s health‐care system. In addition, for the rate of complications, such as postoperative surgical site infections and anastomotic leakage, the capture ratio may differ depending on diagnostic criteria and postoperative care systems, which makes it difficult to carry out a comparison of true incidences. Safety is the most basic requirement for carrying out surgery, and treatment outcomes should be evaluated upon securing a certain safety level. From our perspective, surgery‐related mortality rates are believed to be of utmost importance as indicators for the evaluation of surgical quality.

In Japan, the length of postoperative hospital stays are relatively long and, as a result, the capture ratio is high for postoperative complications, including those that are minor and delayed. Cases of hospital transfer or hospital discharge without alleviation of complications are few, and this could be the reason why surgery‐related mortalities nearly match in‐hospital mortalities. Meanwhile, in Europe and the USA, duration of postoperative hospital stay is often short, and surgery‐related deaths among in‐hospital deaths are difficult to determine. Similarly, 30‐day mortality rates do not reflect all aspects of surgical outcomes or qualities.

The findings of the present study show that postoperative complications categorized as Clavien‐Dindo classification grade III or greater, postoperative complications categorized as Clavien‐Dindo classification grade IV or greater, unplanned postoperative intubations, and cardiac complications are factors with significantly high percentages of mortality within 30 days, irrespective of the type of surgical procedure, and factors with low association with surgical procedures, such as renal dysfunction (distal gastrectomy, right hemicolectomy), central nervous system disorder (right hemicolectomy), sepsis (right hemicolectomy), and septic shock (total gastrectomy, low anterior resection) were also extracted. In contrast, our results also indicated that factors highly associated with the type of surgical procedure, such as reoperation within 30 days and anastomotic leakage, had significantly lower percentages of deaths occurring within 30 days after surgery. Our data show that factors linked to surgery‐related deaths differ depending on the type of surgical procedure, and that when the 30‐day mortality rate was used as a QI for an evaluation of surgery outcome or quality, the capture ratio for the determination of deaths associated with surgical technique‐related complications may be low or otherwise useless, depending on the respective surgical procedure. Furthermore, our data suggest that when the rate of surgical site infections (except those as a result of anastomotic leakage) is high in surgeries other than low anterior resection, the surgery‐related mortality rate is likely to be high even when the 30‐day mortality rate is low. Also, when the rate of anastomotic leakage is high in esophagectomy, total gastrectomy, and distal gastrectomy, the surgery‐related mortality rate is likely to be high, even when the 30‐day mortality rate is low. Similarly, in esophagectomy, right hemicolectomy, pancreaticoduodenectomy, the surgery‐related mortality rate is likely to be high when the rate of reoperation within 30 days is high, even when the 30‐day mortality rate is low, and in hepatectomies with large amounts of bile leakage, surgery‐related mortality rate is likely to be high, even when the 30‐day mortality rate is low and, as a result, surgery‐related mortality may be difficult to evaluate properly.

Meanwhile, in low anterior resections, surgery‐related mortalities can be evaluated properly through evaluation of the 30‐day mortality rate. Thus, in order to evaluate the outcomes or qualities of surgery, the 30‐day mortality rate and other indicators, such as complications, will need to be assessed in combination with outcomes or qualities of surgery. For example, the incidence of anastomotic leakage in total gastrectomy and distal gastrectomy or bile leakage in hepatectomy may be useful. And to use these indicators could fit the actual clinical feelings of surgeons. A comparison with worldwide outcomes or qualities of surgery, or benchmarking, will be necessary to improve the outcomes or qualities of surgery in Japan.[16](#ags312070-bib-0016){ref-type="ref"} However, data regarding Japan, in which surgery‐related mortality is well determined, were based on the Japanese health‐care system, and it remains unknown whether these observations are unique to Japan or are universal and shared worldwide. Our results, which were derived from data collected in Japan, could be used to guide an evaluation of their association with medical circumstances in all countries worldwide, through an international endeavor.

5. CONCLUSION {#ags312070-sec-0017}
=============

The 30‐day mortality rate is definitely useful as a QI for the evaluation of the outcomes or qualities of gastrointestinal cancer surgeries, but it is not necessarily sufficient to cover all types of surgical procedures. Depending on the type of surgical procedure, evaluations of surgical outcome (or qualities) may need to be carried out in combination with the use of the 30‐day mortality rate and other indicators, such as complications.

DISCLOSURE {#ags312070-sec-0019}
==========

Funding: Sources of funding for research and/or publication: The Japanese Society of Gastroenterological Surgery.

Conflicts of Interest: Hiroaki Miyata and Hiroyuki Yamamoto are affiliated with the Department of Healthcare Quality Assessment at the University of Tokyo, and the department is endowed by Johnson & Johnson K.K., Nipro Co., Teijin Pharma Ltd, Kaketsuken K.K., St. Jude Medical Japan Co., Ltd, Novartis Pharma K.K., Taiho Pharmaceutical Co., Ltd, W. L. Gore & Associates, Co., Ltd, Olympus Corporation, and Chugai Pharmaceutical Co., Ltd. None of the organizations had any role in design and conduct of the study, data collection, data analysis, data management, data interpretation, or the preparation, review, approval of this manuscript. The other authors declare that they have no conflicts of interest.

Author Contribution: Substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; T.M., H.Y., S.M., K.K., G.W., H.M., Y.D., M.M. Drafting the article or revising it critically for important intellectual content; T.M., H.Y., S.M., K.K., G.W., H.M. Final approval of the version to be published; Y.S., Y.D., M.M.

We would like to thank the participating surgeons and institutions contributing the data acquisition in NCD. We also would like to thank Mr Koji Sasaki, Secretariat of the Japanese Society of Gastroenterological Surgery, and Mr Naoki Saito, Secretariat of NCD, for their secretarial assistance.
